Streptococcus pneumoniae and Haemophilus influenzae are the key pathog
ens implicated in bacterial infections of the upper and lower respirat
ory tract. Choice of empiric oral antimicrobial chemotherapy is guided
by the clinical presentation, severity of the infection and epidemiol
ogical knowledge, beta-Lactams and the macrolides are the two major gr
oups of antibiotics used to treat respiratory tract infections, The pr
evalence of penicillin-resistant strains of S, pneumoniae is increasin
g world-wide (up to 30% in the USA), as is the prevalence of p-lactama
se-producing strains of H, influenzae. Macrolide resistance in S. pneu
moniae is increasing and is absolute, and some of the macrolides have
only limited activity against H, influenzae. knowledge of local and gl
obal antibiotic resistance patterns should be used as the key to direc
ting empiric choice of antibiotic treatment.